Company Filing History:
Years Active: 2010-2013
Title: Michizane Hashimoto: Innovator in Melanocortin Receptor Modulation
Introduction
Michizane Hashimoto is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the modulation of melanocortin receptors. With a total of 3 patents to his name, Hashimoto's work has the potential to impact various medical conditions.
Latest Patents
One of Hashimoto's latest patents is for Compound WS 727713. This compound is described as a new modulator of melanocortin receptors. The invention details a process for producing WS 727713 by culturing a specific strain and recovering the compound from the culture broth. Additionally, the patent outlines a pharmaceutical composition containing WS 727713 and its various uses, including treatment for ischemia/reperfusion injury, inflammatory diseases, and even conditions like obesity and diabetes mellitus.
Career Highlights
Throughout his career, Michizane Hashimoto has worked with notable companies in the pharmaceutical industry. He has been associated with Astellas Pharma GmbH and Telsar Pharma Inc., where he has contributed to innovative research and development projects. His expertise in the field has allowed him to explore various therapeutic applications for his inventions.
Collaborations
Hashimoto has collaborated with esteemed colleagues such as Takanao Otsuka and Hirotsugu Ueda. These partnerships have fostered a collaborative environment that encourages innovation and the advancement of medical science.
Conclusion
In summary, Michizane Hashimoto is a distinguished inventor whose work in melanocortin receptor modulation has the potential to revolutionize treatments for various health conditions. His contributions to the pharmaceutical industry are noteworthy and continue to inspire future innovations.